Tharimmune, Inc. announced that it has entered into a securities purchase agreement with certain institutional investors to issue 207,292 shares of the Company?s common stock, par value $0.0001 at a price of $3.16 per share for the gross proceeds of $655,042.72 and pre-funded warrants to purchase to 452,253 shares of the common stock at an exercise price of $0.001 per share at a price of $3.16 per share for the gross proceeds of $1,429,119.48 and common warrants to purchase up to 329,771 shares; for total gross proceeds of $2,084,162.2 on June 18, 2024. The Common Warrants are exercisable six months from the date of issuance at an exercise price of $3.09 per share and have a term of exercise equal to five and one-half years from the date of issuance. The Pre-Funded Warrants are exercisable immediately and may be exercised at any time until the Pre-Funded Warrants are exercised in full.

The closing of the Private Placement is expected to occur on June 21, 2024, subject to the satisfaction of customary closing conditions.